Jackie Bosch

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi request reprint Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension
    Jackie Bosch
    Division of Cardiology, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    Circulation 112:1339-46. 2005
  2. pmc Use of ramipril in preventing stroke: double blind randomised trial
    Jackie Bosch
    Canadian Cardiovascular Collaboration, McMaster University, 237 Barton St E, Hamilton, ON, Canada L8L 2X2
    BMJ 324:699-702. 2002
  3. doi request reprint Cognitive impairment and risk of cardiovascular events and mortality
    Martin O'Donnell
    Population Health Research Institute, McMaster University, DBCVS Research Institute, Hamilton, Ontario, Canada
    Eur Heart J 33:1777-86. 2012
  4. ncbi request reprint Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial
    Eva Lonn
    Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Am Coll Cardiol 43:2200-6. 2004
  5. ncbi request reprint Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial
    Eva Lonn
    Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario
    JAMA 293:1338-47. 2005
  6. ncbi request reprint Effect of ramipril on the incidence of diabetes
    Jackie Bosch
    McMaster University, Hamilton, Canada
    N Engl J Med 355:1551-62. 2006
  7. doi request reprint Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone)
    Eva M Lonn
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    J Am Coll Cardiol 53:2028-35. 2009
  8. ncbi request reprint Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy
    Eva Lonn
    Department of Medicine and Population Health Institute, McMaster University, Hamilton, Ontario, Canada
    Diabetes Care 25:1919-27. 2002
  9. ncbi request reprint Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction
    Koon K Teo
    Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    Circulation 110:1413-7. 2004
  10. ncbi request reprint Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients
    Eva Lonn
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Eur J Cardiovasc Prev Rehabil 10:420-8. 2003

Detail Information

Publications23

  1. ncbi request reprint Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension
    Jackie Bosch
    Division of Cardiology, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    Circulation 112:1339-46. 2005
    ..6 years of follow-up and (2) observed in subgroups based on risk and ancillary treatments...
  2. pmc Use of ramipril in preventing stroke: double blind randomised trial
    Jackie Bosch
    Canadian Cardiovascular Collaboration, McMaster University, 237 Barton St E, Hamilton, ON, Canada L8L 2X2
    BMJ 324:699-702. 2002
    ..To determine the effect of the angiotensin converting enzyme inhibitor ramipril on the secondary prevention of stroke...
  3. doi request reprint Cognitive impairment and risk of cardiovascular events and mortality
    Martin O'Donnell
    Population Health Research Institute, McMaster University, DBCVS Research Institute, Hamilton, Ontario, Canada
    Eur Heart J 33:1777-86. 2012
    ....
  4. ncbi request reprint Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial
    Eva Lonn
    Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Am Coll Cardiol 43:2200-6. 2004
    ..The purpose of this study was to assess the effects of ramipril on left ventricular mass (LVM) and function in vascular disease patients with controlled blood pressure (BP) and with preserved left ventricular ejection fraction (LVEF)...
  5. ncbi request reprint Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial
    Eva Lonn
    Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario
    JAMA 293:1338-47. 2005
    ..Experimental and epidemiological data suggest that vitamin E supplementation may prevent cancer and cardiovascular events. Clinical trials have generally failed to confirm benefits, possibly due to their relatively short duration...
  6. ncbi request reprint Effect of ramipril on the incidence of diabetes
    Jackie Bosch
    McMaster University, Hamilton, Canada
    N Engl J Med 355:1551-62. 2006
    ..Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension...
  7. doi request reprint Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone)
    Eva M Lonn
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    J Am Coll Cardiol 53:2028-35. 2009
    ....
  8. ncbi request reprint Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy
    Eva Lonn
    Department of Medicine and Population Health Institute, McMaster University, Hamilton, Ontario, Canada
    Diabetes Care 25:1919-27. 2002
    ..However, data from randomized clinical trials are limited. Therefore, we evaluated the effects of vitamin E supplementation on major CV outcomes and on the development of nephropathy in people with diabetes...
  9. ncbi request reprint Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction
    Koon K Teo
    Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    Circulation 110:1413-7. 2004
    ....
  10. ncbi request reprint Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients
    Eva Lonn
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Eur J Cardiovasc Prev Rehabil 10:420-8. 2003
    ..The prognostic significance of left ventricular hypertrophy (LVH) identified by simple electrocardiographic (ECG) criteria in high-risk patients with established cardiovascular (CV) diseases is not clearly understood...
  11. ncbi request reprint Effect of long-term therapy with ramipril in high-risk women
    Eva Lonn
    Department of Medicine, Division of Cardiology and Population Health Institute, McMaster University, Hamilton, Ontario, Canada
    J Am Coll Cardiol 40:693-702. 2002
    ..We evaluated the effects of long-term therapy with the angiotensin-converting enzyme (ACE) inhibitor ramipril on major cardiovascular (CV) outcomes in high-risk women...
  12. doi request reprint The fluid study protocol: a randomized controlled study on the effects of bioimpedance analysis and vitamin D on left ventricular mass in peritoneal dialysis patients
    Winnie S Su
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Perit Dial Int 31:529-36. 2011
    ....
  13. doi request reprint Setting the record straight on TIDE: a lost opportunity for patients with diabetes
    Zubin Punthakee
    Population Health Research Institute, McMaster University, 1280 Main Street West, HSC 3V51, Hamilton, ON, Canada, L8S 4K1
    Diabetologia 56:1884-7. 2013
    ..As such, we deemed it appropriate to clarify TIDE's objectives, research questions and design and the clinical equipoise regarding its research questions. ..
  14. pmc Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies
    Irene Marzona
    Population Health Research Institute, McMaster University, Hamilton, Ont
    CMAJ 184:E329-36. 2012
    ..We sought to determine the association of atrial fibrillation with cognitive and physical impairment in a large group of patients at high cardiovascular risk...
  15. ncbi request reprint Home and community occupational therapy for children and youth: a before and after study
    Mary Law
    School of Rehabilitation Science, McMaster University, Institute for Applied Health Science, Hamilton, ON
    Can J Occup Ther 72:289-97. 2005
    ..There has been an increased focus on home care service provision in recent years, yet there are few data available about the provision of home and community occupational therapy for children and youth...
  16. ncbi request reprint Independent design and conduct of clinical trials
    Salim Yusuf
    Department of Medicine, Division of Cardiology, McMaster University, Hamilton, Ontario, Canada, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    Clin Trials 3:503-7. 2006
    ..The most frequent type of RCT are those evaluating therapies, and much of this commentary will be focused on issues relevant to such trials, although the principles apply generally...
  17. doi request reprint Sensible guidelines for the conduct of large randomized trials
    Salim Yusuf
    Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada
    Clin Trials 5:38-9. 2008
  18. ncbi request reprint Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study
    J Malcolm O Arnold
    London Health Sciences Centre, London, Canada
    Circulation 107:1284-90. 2003
    ..We assessed an angiotensin-converting enzyme (ACE) inhibitor, ramipril, to prevent the development of heart failure in high-risk patients without known low ejection fraction or heart failure...
  19. ncbi request reprint Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study
    Johannes F E Mann
    Department of Nephrology and Hypertension, Schwabing General Hospital, Munich, Germany
    Kidney Int 65:1375-80. 2004
    ..There are no data for renal insufficiency before the stage of terminal renal failure. We evaluated effects of vitamin E supplementation on cardiovascular and renal outcomes in 993 people with a serum creatinine > or =1.4 to 2.3 mg/dL...
  20. ncbi request reprint Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
    Hertzel Gerstein
    Am Heart J 155:26-32, 32.e1-6. 2008
    ..Thus, targeting normal fasting glucose levels with insulin may reduce CV events. Previous studies suggest that omega-3 fatty acid supplements may reduce CV death; however, their effect in high-risk dysglycemic individuals is not known...
  21. ncbi request reprint Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients
    Monica Gianni
    Department of Medicine, University of Insubria, Varese, Italy
    Eur Heart J 28:1382-8. 2007
    ..Cardiovascular (CV) disease is the leading cause of death in the elderly. The use of ACE-inhibitors in elderly patients with chronic stable vascular disease has not been previously reported...
  22. pmc Preventing stroke with ramipril--authors' reply
    Salim Yusuf
    BMJ 326:52. 2003
  23. ncbi request reprint Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease
    Gilles R Dagenais
    Department of Cardiology, Laval University Heart and Lung Institute, Ste Foy, Quebec, Canada
    Am Heart J 149:54-60. 2005
    ..Increased body mass index (BMI) and abdominal adiposity increase the risk of cardiovascular disease (CVD) in persons free of these diseases, but their independent prognostic impact in persons with CVD has not been well defined...